Jack Schleiffarth, MD
Otolaryngology · Rapid City, SDNPI 1699972000
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (44.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 48.1% of the total. Reporting peaked in 2019 at $5,991 and has fallen 95.9% since, to $247 in 2025. Among otolaryngology clinicians in SD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 128 payments — averaging $101.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$6K
- Acell, Inc.$6K
- Aerin Medical Inc.$353
- Stryker$179
- Advanced Bionics, LLC$127
- CSL Behring$105
- plus $240 from 10 others
What the payments were for
- Travel & lodging$2,05716%
- Food & beverage$5,18940%
- Education$5,74444%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 93 | $6,243 |
| Acell, Inc. | 3 | $5,744 |
| Aerin Medical Inc. | 8 | $353 |
| Stryker | 3 | $179 |
| Advanced Bionics, LLC | 3 | $127 |
| CSL Behring | 5 | $105 |
| Novartis | 3 | $63 |
| Integra Lifesciences Corporation | 2 | $35 |
| Organogenesis Inc. | 1 | $26 |
| Xoran Technologies LLC | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Sanofi | 1 | $19 |
| Cochlear Americas | 1 | $18 |
| Medtronic | 1 | $16 |
| Octapharma USA, Inc. | 1 | $12 |
| GSK | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$2,551
- Inspire Upper Airway Stimulation System$1,539
- VIVAER STYLUS$230
- RHINAER STYLUS$230
- MAKO$148
How this compares
$12,990 in reported general payments places this provider in the 90th percentile of 39 otolaryngology providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 26 | $97,033 |
| Arnuity ElliptaFluticasone Furoate | 20 | $6,676 |
| Pantoprazole Sodium | 118 | $1,512 |
| Ipratropium Bromide | 60 | $1,509 |
| Azelastine Hcl | 39 | $974 |
| Fluticasone Propionate | 37 | $500 |
| Ofloxacin | 17 | $363 |
| Montelukast Sodium | 17 | $276 |
| Mupirocin | 22 | $275 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 29 | $228 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 11 | $195 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $127 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $114 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 21 | $109 |
| Prednisone | 35 | $70 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKArnuity Ellipta | $12 | $6,67620 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 39 otolaryngology providers in South Dakota.
Other otolaryngology in Rapid City
- Nicholas ColwellRapid City$2K
- Liam DuffyRapid City$2K
- Dallin ChristensenRapid City$2K
- Troy HowardRapid City$2K
- Robert BurgessRapid City$1K
- Skye LawlorRapid City$905
- Vaughan BowenRapid City$864
- Ronald GuyRapid City$468
- Gary CarlsonRapid City$47
- Sarah PowellDakota Dunes$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.